2024 U.S.-Japan Healthcare Connection Reverse Pitch Event
US-Japan Healthcare Connection Reverse Pitch Event
Thursday, June 13, 2024
8:30AM – 10:30AM
Computer History Museum
1401 N. Shoreline Blvd.
Mountain View, CA 94043
Link
11 Japanese corporations will deliver short presentations explaining their strategic and investment priorities to an audience of high-profile medtech startups and others at a Reverse Pitch event organized by the US-Japan Healthcare Connection as part of the Medtech Innovator (MTI) Annual Innovator Summit. The Reverse Pitch Event and MTI Summit will be held at the Computer History Museum in Mountain View, CA on Thursday, June 13, 2024.
The Reverse Pitch program is designed to introduce Japanese companies that are highly interested in the healthcare/medtech industry as potential strategic partners and/or investors in early-stage medtech ventures. After the presentations, the presenting companies will be available to meet individually with Summit attendees to discuss areas of mutual interest. Companies that will be presenting are:
- CMIC
- Fujikura
- Mitsubishi Corporation
- Nipro
- Nissan Chemicals
- Niterra Ventures
- Recor Medical
- Sysmex
- Teijin Pharma
- Terumo
- xCare
The tentative schedule for this event is 8:30-10:30 a.m., and attendance is limited to companies that have been pre-approved to participate. If you are interested in attending, please contact us at admin@usajapan.org.
8:00 A.M. – 8:30 A.M.
REGISTRATION
8:30 A.M. – 10:30 P.M.
PRIVATE EARLY STAGE AND PRIVATE COMPANY PRESENTATIONS
Kento Nakamura is part of the Strategy and Corporate Development team at CMIC since September 2023. He was previously at KM Pharmaceutical Consulting where he worked closely with the clinical development team, and at McCann Health where he broke down complex biological concepts to effectively communicate with non-scientific people. Kento holds a Master’s in Public Health degree from Harvard University and a bachelor’s degree in biology from Tufts University. He is delighted to be back in the Bay Area where he used to live from 2021 to 2023 and considers it to be his home in the US.
Company Info:
CMIC is a service provider for biotech and med tech companies trying to advance their products through clinical development, especially in Asia Pacific. We are joining this program to introduce ourselves to companies that may want to develop their products in Asia Pacific.
As Application Engineering Manager at Fujikura America, Kazuhiro Iwamoto is responsible for providing solutions using Fujikura products to address customer issues and supporting development in the medical and information equipment fields.
Kazuhiro has a Master of Engineering of Tokyo University of Science.
Company Info:
Fujikura is a nearly 140-year-old company based in Tokyo, Japan. A leading technology developer and manufacturer of Fiber Optics, Optical Components and Electrical Wiring, our focus is on the Medical, Automotive, Consumer Electronics and Telecommunications markets. By providing advanced technologies and engineering to our customers, Fujikura is a reliable technology solutions partner delivering high-quality, reliable solutions.
Within the medical industry, Fujikura offers class-leading CMOS technologies for the disposable endoscope market, long format Flexible Printed Circuitry [FPC] for robotic and catheter-based applications, as well as miniaturized interconnect solutions to reduce cost and touch time with improved reliability for medical devices. With a global manufacturing base, we can offer cost-competitive manufacturing in ISO13485 and FDA-cleared facilities in Vietnam and Thailand. Our focus on interconnectivity, visualization and miniaturization while maintaining the highest quality and reliability makes Fujikura a driver of medical technology advancement.
Kayo Kobayashi is an Associate in the Healthcare Department and a registered nurse in Japan. She oversees business development in the Bay Area, with a focus on creating business partnerships with North American medtech companies that have the potential to enter the Japanese market. Additionally, she is engaged in an accelerator program for Japanese startups seeking to expand their business in the U.S.
Company Info:
Mitsubishi Corporation (Americas) is a wholly owned subsidiary of Mitsubishi Corporation, a global integrated business enterprise with 8 business groups that operate across virtually every industry. In the healthcare space, Mitsubishi Corporation covers a wide range of businesses, including medical devices, supply chains, digital health, healthcare service, elderly care, and wellness. In the medtech business, Mitsubishi Corporation focuses on general surgery, laparoscopic surgery, orthopedic, OB/GYN, urology, GI, ENT, respiratory/anesthesia, radiology, and cardiology. Mitsubishi Corporation has long-term partnership agreements with U.S. and European medtech startups in the Japanese market to facilitate various functions such as importing, sales and marketing, regulatory filing, and quality management.
Hisatoshi Abe is based in Sunnyvale, California, and leads NIPRO’s business development activities. Before coming to the US, he worked at NIPRO’s R&D center in Japan developing pharmaceutical containers. From 2018 to 2019, he participated in the 4th Fellowship Program of Japan Biodesign to learn about innovation in medical device development
Company Info:
If you have plans to enter the Japanese market, don’t hesitate to contact NIPRO. We have four
business segments: Medical Device, Pharmaceutical, Pharma Packaging, and Regenerative
Medicine. Our hemodialysis products, the flagship of our medical device business, are used
worldwide. In Japan, we handle not only dialysis products but also various classes of medical
devices
Norio Hashimoto is the General manager for Business Development Department of Nissan Chemical America Corporation. Norio specialized in business development in the healthcare field and is responsible for promoting new business development in the US and Europe. He graduated from Osaka University of Pharmaceutical Science and had worked as a pharmacological researcher for over 15 years. He has 8 year-experience working in the US and started some collaborations with US and companies/academia.
Company Info:
Nissan Chemical Corporation was founded in 1887 as the first chemical fertilizer manufacturer in Japan. Since then, Nissan Chemical has continuously aimed at innovation and now manufactures outstanding products in areas such as industrial chemicals, electrical materials, agrochemicals, and pharmaceuticals.
Nissan Chemical is seeking new business opportunities in Healthcare, Environmental & Energy, and Information communication through the collaboration, in-license and strategic investment to establish new business pillar for the future. Our focused area in Healthcare is RNA-related drug discovery, manufacturing for cell therapies, and materials/technologies for diagnosis and drug discovery. We are hoping to discuss with companies/academia for the flexible collaborations.
Tom Kluz serves as the Managing Partner at Niterra Ventures, spearheading global investments on behalf of Niterra Co., LTD across medical, energy & environment, and mobility sectors. While he oversees investment endeavors in all these domains, Tom is particularly renowned for his deep expertise in healthcare. This distinction stems from a decade-long stint as the Head of Global Healthcare Investing at Qualcomm Ventures and a pivotal role at Providence Ventures.
Company Info:
Niterra Ventures is the corporate venture capital arm of Niterra Global, a Japanese conglomerate focused on the automotive tech and medtech sectors. The investment program on the medical side is focused on respiratory care, women’s health and home health. We are stage agnostic and like to work closely with entrepreneurs to enable them to achieve their high growth dreams.
Kenichiro Kubo (DDS, MBA) is a seasoned professional with a 15-year tenure in the healthcare industry, beginning his journey as a dentist after graduating from dental school. His diverse experience spans across management consulting, pharmaceutical marketing, medical device marketing, and investment, with a particular focus on general management within Southeast Asia. Currently, Kenichiro holds a pivotal project management role at Recor Medical, a subsidiary of Otsuka Holdings, where he oversees key cross-divisional projects. His multifaceted background equips him with a unique perspective on the healthcare market, making him a valuable asset to the industry.
Company Info:
Medical Device business is a new and the next generation business and one of the investment targets for Otsuka.
Disease focus is Cardiovascular/Renal area.
Our interests are in anything synergistic with our current business, especially technologies for Hypertension, Kidney disease, Atrial Fibrillation, Heart Failure.
Kenjiro Fujio
Kenjiro leads growth initiatives related to digital health and digital therapeutics. In that capacity, he is particularly eager to meet with early-stage companies developing innovative new digital diagnostic and therapeutic solutions.
Before joining Sysmex, he held a position at Omron Healthcare, where he led the global development of the remote patient monitoring system business. He received his bachelor’s degree in Environment and Information studies from Keio University and is now pursuing Master of Business Administration from Indiana University, Kelley business school.
Shrey Singh
Shrey is determined to uncover latent needs of patients to solve unmet needs in healthcare. A former program manager in Sysmex Japan, now focusing on digital health strategy in the Bay Area.
Company Info:
RDCA is a wholly owned subsidiary of Sysmex Corporation, focused on realizing preventive medicine and bringing next–gen clinical applications from the US to our sales channel globally. Our objective is to seek collaborations with the SV ecosystem for building our digital healthcare footprint.
Yosuke Matsubara is a Business Development and Licensing Manager at Teijin Pharma, a company in Japan’s pharmaceutical and medical device sectors. He earned his Ph.D. in medical science before joining Teijin Pharma in 2008. With over a decade of experience in drug development, Yosuke is skilled in clinical trials, regulatory approvals, and project management. In 2017, he obtained his Project Management Professional (PMP) certification. Since 2022, Yosuke has been working in the US, focusing on sourcing innovative products for the Japanese market. His role involves fostering collaborations and partnerships with startups in the medical device and pharmaceutical industries. Many of Teijin Pharma’s products are sourced internationally, and Yosuke plays a key role in licensing activities. He also collaborates with venture capital partners in the US, leveraging Teijin’s venture capital fund to enhance the licensing-in process.
Company Info:
Teijin Pharma’s medical device division focuses on home-use devices, including CPAP ventilators for OSA patients and Home Oxygen Therapy for COPD patients, where we hold a leading market position in Japan. Our goal is to support patients in their homes and communities, ensuring they receive the care they need in familiar surroundings. We are actively exploring the introduction of new medical equipment and services to enhance patient care in Japan.
Yushin Yazaki is currently the Director of Venture Arm at Terumo Corporation. Previously, he held the position of Global Products Manager in the same company. Yushin received his Master’s degree from Hitotsubashi ICS (Hitotsubashi University Business School) and his PhD in Materials Science from Waseda University.
Company Info:
Terumo has three companies; Cardiac and Vascular Company, Blood and Cell Technologies Company, and Medical Care Solutions Company.
The businesses of the Cardiac and Vascular Company involves the heart, lung, and brain, and treatment of blood vessel diseases throughout the body. The company provides interventional devices, oxygenators and heart-lung machines, and surgical grafts and stent grafts globally.
Blood and Cell Technologies Company provides collection and processing sets and other supplies for efficient blood processing. Additionally, the company provides devices that use centrifugation and separation technology to collect or remove specific blood components, enabling a variety of blood treatment solutions. In the fields of cell and gene therapy, the company provides research institutions and pharmaceutical companies with instruments and services that enable high-quality, large-scale production of cell products to support the creation of new therapies.
Different from above two Companies, Medical Care Solutions Company is doing the business broadly, but mainly focusing Japanese market. The company offers a variety of expertise to address the needs of those in medical care settings, including medical safety, in-facility infection prevention, and cost control. These include advanced infusion system, peritoneal dialysis, infection prevention and environmental control, preoperative and oncological products. Chronic diseases are also their focus. The company provides the products in the areas of diabetes care, heart failure care, and vital sign management in hospital and home settings. Additionally, the company offers solutions to pharmaceutical companies globally by proposing new drug delivery devices. They leverage its material technology optimized for the characteristics of each drug and utilizes advanced manufacturing technology to design and produce drug-device combination products. Through alliances with pharmaceutical companies, they provide a total solution from clinical trial drug manufacture to full commercialization.
Masaru Fukunaga is the founder and CEO of xCARE Inc. After working as a medical representative for Dainippon Sumitomo Pharma, he worked as a consultant for Element HRC Co. He has knowledge of the medical business covers from drug discovery to regulatory clearance in the development phase as well as from upstream to downstream in the marketing phase. He has a wide range of networking with various medical business personnel and pharmaceutical/medical device companies. He established xCARE for the purpose of accelerating innovation in the medical business by offering the services to solve the issue of human resources in the companies.
Company Info:
xCARE is an innovative medical business platform in active development, offering crucial functionalities such as “Matching” and “Project Management.” in the field of medical business (pharmaceuticals, MedTech, regenerative medicine).
We have, so far, a diverse pool of over 200 registered experts. Our “Matching” capability assembles dynamic teams proficient in product development, regulatory affairs, clinical trials, and quality management systems. Meanwhile, our robust “Project Management” ensures precise control over tasks with an unwavering focus on quality.
Presently, xCARE is dedicated to delivering hands-on and recruitment support. Our project manager-led services have garnered high praise, particularly from global companies, especially startups, seeking short-to-medium-term resources for business development without the commitment of permanent hires. While providing these services, xCARE is actively refining its platform, with plans to open it to companies and partners in the upcoming phase.
Through this program, we are looking forward to getting contact from investors have interest of xCARE’s business and from potential partners and startups are interested in xCARE’s services as well as experts are interested in registering at xCARE platform.